Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusionSangwoo Ham, Yunjong Lee, Seung Pil Yun et al.|Science Translational Medicine|2020Cited by 29
ATF4-activated parkin induction contributes to deferasirox-mediated cytoprotection in Parkinson’s diseaseSangwoo Ham, Yunjong Lee, Ji Hun Kim et al.|Toxicological Research|2022Cited by 9
Involvement of CYP3A4 and MDR1 in altered metabolism and transport of indinavir in 1,25(OH)2D3-treated Caco-2 cellsSujin Lee, Han‐Joo Maeng, Seul-A Joo et al.|European Journal of Pharmaceutical Sciences|2023Cited by 8
Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson’s DiseaseSangwoo Ham, Yunjong Lee, Heejeong Kim et al.|International Journal of Molecular Sciences|2019Cited by 7
Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s diseaseJeong‐Yong Shin, Yunjong Lee, Bina Lee et al.|Biomedicine & Pharmacotherapy|2022Cited by 7